Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | -0.55% | 243.51 | 1.5% | $937.22m | |
| MRNA | Moderna, Inc. | -2.18% | 142.19 | 0.0% | $805.88m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.33% | 594.42 | 2.6% | $512.04m | |
| GILD | Gilead Sciences, Inc. | -0.99% | 62.21 | 1.0% | $507.75m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -3.88% | 276.17 | 1.9% | $501.77m | |
| NVAX | Novavax, Inc. | -5.13% | 51.06 | 75.7% | $417.14m | |
| ILMN | Illumina, Inc. | -3.06% | 187.43 | 3.3% | $357.53m | |
| BIIB | Biogen, Inc. | -5.18% | 202.51 | 1.8% | $242.18m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 2.77% | 3.34 | 0.7% | $233.48m | |
| CRSP | CRISPR Therapeutics AG | -5.41% | 63.28 | 0.6% | $169.89m | |
| BNTX | BioNTech SE | -2.71% | 139.82 | 0.0% | $166.88m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -2.28% | 83.15 | 4.2% | $123.51m | |
| EXAS | EXACT Sciences Corp. | -6.78% | 41.11 | 17.7% | $99.49m | |
| IOVA | Iovance Biotherapeutics, Inc. | -1.35% | 10.98 | 0.0% | $95.65m | |
| TECH | Bio-Techne Corp. | -2.07% | 346.01 | 4.5% | $93.22m |
Company Profile
Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527 and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology. The ADAPTIR and ADAPTIR-FLEX are capable of generating differentiated bispecific and multi-specific antibodies with potentially unique mechanisms of action for the treatment of different types of cancer. The company was founded on February 22, 2016 and is headquartered in Seattle, WA.